Contents
[hide]
[show]

The TARDBP gene is a genetic coding sequence that is responsible for producing proteins involved in the regulation of gene expression. This gene is listed on various scientific databases, including OMIM and PubMed, where it is associated with several health conditions and diseases. One of the most well-known and studied conditions related to the TARDBP gene is amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease.

TARDBP gene changes and variants have been found to be a significant factor in the development of ALS. Studies have shown that mutations in this gene can lead to the production of abnormal proteins, specifically the TDP-43 protein, which is known to be involved in the progressive nerve cell damage characteristic of ALS. The exact mechanisms by which these gene changes cause ALS are still being investigated.

In addition to ALS, the TARDBP gene has also been linked to other neurodegenerative disorders, including frontotemporal lobar degeneration and Parkinson’s disease. The gene’s role in these conditions is still not fully understood, but researchers believe that changes in the TARDBP gene may contribute to the development and progression of these diseases.

Testing for TARDBP gene variants and changes can be done through genetic testing. These tests can analyze an individual’s DNA to identify any mutations or alterations in the TARDBP gene. This information can be valuable in diagnosing and understanding the underlying causes of certain health conditions and may help guide patient management and treatment decisions.

Further research and scientific studies are ongoing to better understand the TARDBP gene and its role in various diseases. The information gathered from these studies could have implications for the development of new therapies and treatment options for patients with ALS, Parkinson’s disease, and other related conditions.

Genetic changes in the TARDBP gene can lead to various health conditions. These changes can be inherited from parents or occur spontaneously during a person’s lifetime. Testing for genetic changes in the TARDBP gene can be done to diagnose or predict these health conditions.

It’s not just health insurance premiums, but also deductibles, that keep on rising. In 2018, the average deductible was $3,000 for a gold-tier family plan, $8,000 for a silver-tier family plan and $12,000 for a bronze-tier family plan, according to USC Annenberg’s Center for Health Journalism.

Genetic changes in the TARDBP gene have been catalogued in various databases and resources. The OMIM database and PubMed are two scientific databases that provide information on genetic changes in the TARDBP gene and their related health conditions. These databases list names and variants of the gene, as well as references to additional articles and resources for further information.

Some of the health conditions caused by genetic changes in the TARDBP gene include:

  • Amyotrophic lateral sclerosis (ALS)
  • Frontotemporal dementia (FTD)
  • Progressive supranuclear palsy (PSP)
  • Multisystem proteinopathy (MSP)
  • Motor neuron disease (MND)

These conditions are characterized by progressive degeneration of nerve cells, leading to muscle weakness, cognitive impairment, and other neurological symptoms. The TARDBP gene encodes the TDP-43 protein, which is involved in the regulation of gene splicing and other cellular processes. Genetic changes in this gene can disrupt the normal function of TDP-43, leading to the development of these disorders.

Genetic testing for changes in the TARDBP gene can be performed to confirm a diagnosis or assess the risk of developing these conditions. Various tests are available, including DNA sequencing and analysis of the TDP-43 protein. These tests can be obtained through specialized laboratories and clinics.

It is important to note that genetic changes in the TARDBP gene are not the only cause of these health conditions. Other genes and environmental factors can also contribute to their development. Genetic counseling and further medical evaluation may be necessary to fully understand the underlying causes and treatment options for individuals with these conditions.

References:

  1. Brouwers N, et al. Genetic variability in the TARDBP gene is not associated with risk of ALS or age at onset. Neurology. 2008;71(4):266-9.
  2. Da

    Amyotrophic lateral sclerosis

    Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease, is a progressive neurodegenerative condition that affects nerve cells in the brain and spinal cord. It primarily leads to the loss of muscle control and eventually results in paralysis.

    ALS can be caused by various factors, including genetic changes. One of the genes associated with ALS is the TARDBP gene. Variants in this gene have been found to be linked to the development of ALS.

    Research articles and studies have reported the involvement of TARDBP gene variants in ALS and other related conditions. These variants can lead to changes in the regulation and splicing of TDP-43 proteins, which are crucial for normal nerve cell function.

    To determine the presence of TARDBP gene variants and assess the risk of developing ALS, genetic tests can be conducted. These tests analyze the genetic information and identify any changes in the TARDBP gene that may contribute to the condition.

    In addition to the TARDBP gene, several other genes have been associated with ALS. These genes play a role in various processes related to nerve cell health and function. Testing for these genes can provide further information on the genetic factors influencing the development of ALS.

    Databases and resources such as OMIM, PubMed, and gene catalogs can provide valuable information on the TARDBP gene and other related genes. These resources aggregate scientific articles, references, and additional information on genes, diseases, and conditions.

    Testing for TARDBP gene variants and other associated genes can aid in the diagnosis of ALS and other related disorders. Early detection and diagnosis contribute to better management and treatment of the condition.

    In summary, amyotrophic lateral sclerosis is a progressive neurodegenerative condition primarily caused by the loss of nerve cell function. The TARDBP gene and other related genes play a crucial role in the development of ALS. Genetic testing and information from databases and resources can help in the understanding, diagnosis, and management of this condition.

    Other disorders

    In addition to amyotrophic lateral sclerosis (ALS), variants in the TARDBP gene have also been linked to other neurodegenerative disorders. These disorders are characterized by the progressive loss of motor neurons and nerve cells.

    Genes related to these disorders can be identified through genetic testing, which can detect changes or variants in the TARDBP gene. Testing for these conditions is usually done through sequencing the exons and intron-exon boundaries of the TARDBP gene.

    References to articles on the regulation and splicing of TARDBP and other genes associated with these disorders can be found in scientific databases, such as PubMed and OMIM. These databases provide additional information on genetic changes, proteins, and other related conditions.

    Some of the disorders related to TARDBP gene variants include:

    • Frontotemporal dementia (FTD)
    • Familial dysautonomia
    • Glioblastoma
    • Alzheimer’s disease

    Information on these disorders and their relationship to the TARDBP gene can be found in the scientific literature, as well as in disease registries and catalog resources.

    Genetic testing for variants in the TARDBP gene can help identify individuals at risk for these disorders. Early detection and intervention can be critical for managing symptoms and improving outcomes.

    Other Names for This Gene

    • TDP-43 gene
    • TAR DNA-binding protein
    • TARDBP variant
    • TDP-43 testing
    • TARDBP catalog
    • TARDBP registry
    • TARDBP articles
    • TARDBP caused tests
    • TARDBP genetic regulation
    • TARDBP related diseases
    • TARDBP scientific changes
    • TARDBP splicing
    • TARDBP references

    For additional information about genes related to TARDBP, see the following resources:

    1. OMIM (Online Mendelian Inheritance in Man): This database provides information on genetic disorders and conditions.
    2. PubMed: A search engine for scientific articles.
    3. PubGene: A database for genes and proteins.

    Changes in the TARDBP gene have been associated with various conditions, including amyotrophic lateral sclerosis (ALS) and progressive lateral sclerosis (PLS). Testing for these changes can help with diagnosis and management of these disorders.

    Additional Information Resources

    For additional information on the TARDBP gene, the following resources may be helpful:

    • Genetic Testing: There are genetic testing options available to identify changes in the TARDBP gene. These tests can be useful for diagnosing and managing certain disorders.
    • Scientific Databases: Various scientific databases provide information on genes, diseases, and related conditions. These databases can be useful for researchers and healthcare professionals. Some examples include PubMed, OMIM, and the Genetic Testing Registry.
    • Related Articles: Scientific articles related to TARDBP and its associated conditions can provide further insights into the gene and its roles in diseases such as amyotrophic lateral sclerosis. PubMed is a valuable resource for accessing these articles.
    • Protein Regulation and Splicing: Understanding the regulation and splicing of TARDBP and its encoded protein, TDP-43, is crucial for understanding its function and potential implications in diseases. Further research in this area can shed light on the mechanisms and potential therapeutic targets.
    • Health Registry: Joining a health registry specific to TARDBP-related conditions can provide individuals and families with information, support, and opportunities to participate in research studies.

    These resources offer valuable information and tools for studying the TARDBP gene and its implications in various disorders. Further research and exploration of these resources can contribute to advancements in the understanding and management of TARDBP-related conditions.

    Tests Listed in the Genetic Testing Registry

    The TARDBP gene, also known as tdp-43, is associated with various health conditions and disorders. Genetic testing can identify changes or variants in this gene, providing important information about an individual’s risk for developing certain disorders or conditions.

    The Genetic Testing Registry (GTR) lists several tests related to the TARDBP gene and its associated conditions. These tests can help identify genetic changes or variants in the TARDBP gene, which may be linked to the development of certain disorders.

    The GTR catalogs various tests for amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease. ALS is a progressive neurodegenerative disorder that affects nerve cells in the brain and spinal cord. Changes or variants in the TARDBP gene have been associated with ALS, and genetic testing can help determine a person’s risk for developing this condition.

    Additional tests listed in the GTR include those for other related conditions, such as frontotemporal lobar degeneration and other forms of progressive motor neuron disease. These conditions may also be linked to changes in the TARDBP gene, and genetic testing can provide valuable information about an individual’s risk.

    The GTR provides comprehensive information about each listed test, including the test name, the condition or disorder it is related to, the genes analyzed, and the laboratories offering the test. This information can help healthcare professionals and individuals make informed decisions about genetic testing.

    In addition to the GTR, other databases and resources such as PubMed and OMIM also contain information on tests related to the TARDBP gene. These scientific databases include articles, references, and other references on genetic testing for TARDBP gene-associated conditions.

    Genetic testing for TARDBP gene variants can provide valuable insights into an individual’s risk for developing certain health conditions and disorders. Understanding the genetic changes associated with these conditions can help in their diagnosis, treatment, and management.

    In conclusion, the Genetic Testing Registry and other scientific resources provide information about tests related to the TARDBP gene and its associated conditions. These tests can help identify genetic changes or variants that may be linked to the development of various health conditions and disorders, including ALS and other progressive motor neuron diseases.

    Scientific Articles on PubMed

    PubMed is a widely used database that provides access to a vast collection of scientific articles and references related to various health conditions. In the context of the TARDBP gene, which is associated with amyotrophic lateral sclerosis (ALS) and other progressive disorders, PubMed is a valuable resource for finding information on the genes, proteins, and genetic changes that contribute to these conditions.

    By searching PubMed using keywords such as “TARDBP gene,” “amyotrophic lateral sclerosis,” and “TDP-43,” researchers can find a wealth of scientific articles and studies that discuss the role of this gene in disease development and progression.

    PubMed contains a comprehensive catalog of scientific articles that are related to the TARDBP gene. These articles cover a wide range of topics, including the regulation and splicing of this gene, changes in the TDP-43 protein, and the impact of these changes on nerve function and other biological processes.

    In addition to articles specifically focusing on the TARDBP gene, PubMed also lists references to articles that discuss the genetic changes and variants associated with disorders such as ALS, frontotemporal lobar degeneration, and ALS-FTD. These conditions are often caused by mutations in the TARDBP gene or changes in the TDP-43 protein.

    PubMed provides a valuable resource for researchers and healthcare professionals looking to stay up to date with the latest scientific findings in the field of TARDBP gene and related conditions. By using PubMed, they can access articles from various scientific journals and databases, ensuring the availability of a wide range of perspectives and research studies.

    Furthermore, PubMed offers additional resources for researchers, such as OMIM (Online Mendelian Inheritance in Man) and the Genetic Testing Registry. These databases provide information on genetic testing options, variant names, and other relevant details for patients and healthcare providers.

    In summary, when researching the TARDBP gene and related conditions, PubMed is an indispensable tool. Its vast collection of scientific articles helps researchers and healthcare professionals stay informed about the latest discoveries in the field and understand the genetic changes and protein alterations that contribute to the development and progression of ALS, frontotemporal lobar degeneration, and other related diseases.

    Catalog of Genes and Diseases from OMIM

    The TARDBP gene, also known as TAR DNA-binding protein 43, is associated with several neurological disorders. These conditions are mainly related to progressive nerve changes and include amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD). The TARDBP gene plays a crucial role in the regulation of gene expression and splicing.

    OMIM, the Online Mendelian Inheritance in Man database, is a comprehensive registry of genes and genetic disorders. In the case of TARDBP, OMIM provides valuable information for scientific research, genetic testing, and health-related resources.

    OMIM lists additional diseases and conditions caused by changes in the TARDBP gene. These include various forms of ALS, FTLD, and other related neurological disorders. The database also includes references to relevant scientific articles from PubMed.

    For individuals or healthcare professionals seeking genetic testing or more information about TARDBP-related diseases, OMIM is a valuable resource. The database provides detailed descriptions, genetic testing resources, and references to further research articles.

    By utilizing OMIM and other databases, scientists and healthcare professionals can better understand the relationship between the TARDBP gene and neurological conditions. This knowledge can lead to improved diagnostic tests, treatment options, and potential therapeutic interventions.

    Overall, OMIM serves as an essential catalog of genes, diseases, and conditions. It provides valuable information for researchers, healthcare professionals, and individuals seeking a better understanding of genetic disorders.

    Gene and Variant Databases

    Gene and variant databases provide valuable information for researchers and clinicians studying the TARDBP gene and its associated variants. These databases compile and organize information from scientific articles, tests, and other resources related to genes, proteins, and genetic disorders.

    One of the most widely used databases for gene and variant information is PubMed. It is a comprehensive resource that includes references to scientific articles on various topics, including TARDBP gene and related conditions. Researchers and clinicians can search PubMed to find articles that discuss the TARDBP gene, its variants, and their association with diseases and conditions.

    In addition to PubMed, there are other databases that specifically focus on genes and genetic disorders. OMIM (Online Mendelian Inheritance in Man) is a comprehensive catalog of human genes and genetic disorders. It provides detailed information on the TARDBP gene, including its function, variants, and associated diseases.

    The ALS Online Genetics Database is another valuable resource for studying the TARDBP gene. It is a registry of genetic changes associated with amyotrophic lateral sclerosis (ALS) and related conditions. The database provides information on genetic variants identified in ALS patients and their impact on the regulation and splicing of the TARDBP gene.

    Genetic testing companies also maintain their own databases of gene and variant information. These databases provide information on genetic variants and their association with certain conditions. Genetic testing can be used to identify variants in the TARDBP gene that may be causing changes in its function and contribute to the development of diseases.

    Overall, gene and variant databases are valuable resources that provide researchers and clinicians with important information on the TARDBP gene and its associated variants. These databases compile information from scientific articles, genetic testing results, and other sources to create a comprehensive and up-to-date repository of knowledge on the TARDBP gene and related conditions.

    References

See also  Type 1 diabetes

Related Posts